These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 474641

  • 21. An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.
    Allen MM, Douds JJ, Liang SX, Desouki MM, Parkash V, Fadare O.
    Int J Clin Exp Pathol; 2015; 8(3):2795-801. PubMed ID: 26045786
    [Abstract] [Full Text] [Related]

  • 22. [Clinical pathology of uterine smooth muscle tumors--borderline lesions between leiomyomas and leiomyosarcomas].
    Fujii S.
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Mar; 40(3):385-90. PubMed ID: 3361191
    [No Abstract] [Full Text] [Related]

  • 23. [Histopathological, clinical and prognostic aspects of smooth-muscle tumors of the uterus (cellular myoma, leiomyosarcoma, endometrial stromal sarcoma)].
    De Giacomo G, Palla G, Paparatti L, Villani L, Moneta E.
    Minerva Ginecol; 1988 Feb; 40(2):73-81. PubMed ID: 3399122
    [No Abstract] [Full Text] [Related]

  • 24. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors.
    Sgantzos MN, Galani V, Arvanitis LD, Charchanti A, Psathas P, Nakou M, Havaki S, Kallioras V, Marinos E, Vamvakopoulos NC, Kittas C.
    Pathol Res Pract; 2007 Feb; 203(1):31-7. PubMed ID: 17129677
    [Abstract] [Full Text] [Related]

  • 25. Correlation between DNA ploidy and clinical features in smooth muscle tumors of the gastrointestinal tract.
    Kimura H, Yonemura Y, Kadoya N, Kosaka T, Miwa K, Miyazaki I, Sawa T, Yoshimitsu S, Nishida Y, Kamata T.
    Anal Cell Pathol; 1993 Nov; 5(6):331-8. PubMed ID: 8305329
    [Abstract] [Full Text] [Related]

  • 26. Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings.
    Tanaka YO, Nishida M, Tsunoda H, Okamoto Y, Yoshikawa H.
    J Magn Reson Imaging; 2004 Dec; 20(6):998-1007. PubMed ID: 15558559
    [Abstract] [Full Text] [Related]

  • 27. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic comparison of leiomyoma and leiomyosarcoma.
    Martin SA, Sears DL, Sebo TJ, Lohse CM, Cheville JC.
    Am J Surg Pathol; 2002 Mar; 26(3):292-300. PubMed ID: 11859200
    [Abstract] [Full Text] [Related]

  • 28. [Malignancy of uterine sarcoma in comparison with suspect leiomyoma. An anatomo-clinical study of 16 cases].
    Socolov RV, Pricop FZ, Stratan D.
    Rev Fr Gynecol Obstet; 1992 Oct; 87(10):457-60. PubMed ID: 1470817
    [Abstract] [Full Text] [Related]

  • 29. Reduced expression of calponin h1 in leiomyosarcoma of the uterus.
    Horiuchi A, Nikaido T, Ito K, Zhai Y, Orii A, Taniguchi S, Toki T, Fujii S.
    Lab Invest; 1998 Jul; 78(7):839-46. PubMed ID: 9690561
    [Abstract] [Full Text] [Related]

  • 30. Uterine adenomyoma: a clinicopathologic review of 26 cases and a review of the literature.
    Tahlan A, Nanda A, Mohan H.
    Int J Gynecol Pathol; 2006 Oct; 25(4):361-5. PubMed ID: 16990713
    [Abstract] [Full Text] [Related]

  • 31. Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner-Adler B, Bodner K, Kimberger O, Czerwenka K, Leodolter S, Mayerhofer K.
    J Soc Gynecol Investig; 2004 Apr; 11(3):182-6. PubMed ID: 15051038
    [Abstract] [Full Text] [Related]

  • 32. Expression of thrombospondin 1 (TSP 1) in patients with uterine smooth muscle tumors: an immunohistochemical study.
    Bodner-Adler B, Nather A, Bodner K, Czerwenka K, Kimberger O, Leodolter S, Mayerhofer K.
    Gynecol Oncol; 2006 Oct; 103(1):186-9. PubMed ID: 16595146
    [Abstract] [Full Text] [Related]

  • 33. [Leiomyosarcoma of the uterus--a clinicopathologic analysis of 11 cases].
    He WC.
    Zhonghua Zhong Liu Za Zhi; 1990 Nov; 12(6):444-6. PubMed ID: 2076642
    [Abstract] [Full Text] [Related]

  • 34. Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors.
    Liegl-Atzwanger B, Heitzer E, Flicker K, Müller S, Ulz P, Saglam O, Tavassoli F, Devouassoux-Shisheboran M, Geigl J, Moinfar F.
    Mod Pathol; 2016 Oct; 29(10):1262-77. PubMed ID: 27363490
    [Abstract] [Full Text] [Related]

  • 35. Apoplectic leiomyomas of the uterus. A clinicopathologic study of five distinctive hemorrhagic leiomyomas associated with oral contraceptive usage.
    Myles JL, Hart WR.
    Am J Surg Pathol; 1985 Nov; 9(11):798-805. PubMed ID: 4073354
    [Abstract] [Full Text] [Related]

  • 36. PD-L1 Expression and Tumor-infiltrating Lymphocytes in Uterine Smooth Muscle Tumors: Implications for Immunotherapy.
    Shanes ED, Friedman LA, Mills AM.
    Am J Surg Pathol; 2019 Jun; 43(6):792-801. PubMed ID: 31009388
    [Abstract] [Full Text] [Related]

  • 37. Pathology, cytogenetics and molecular biology of uterine leiomyomas and other smooth muscle lesions.
    Quade BJ.
    Curr Opin Obstet Gynecol; 1995 Feb; 7(1):35-42. PubMed ID: 7742513
    [Abstract] [Full Text] [Related]

  • 38. Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS).
    Mayerhofer K, Lozanov P, Bodner K, Bodner-Adler B, Kimberger O, Czerwenka K.
    Acta Obstet Gynecol Scand; 2004 Nov; 83(11):1085-8. PubMed ID: 15488127
    [Abstract] [Full Text] [Related]

  • 39. Uterine leiomyomas with high content of mast cells.
    Maluf HM, Gersell DJ.
    Arch Pathol Lab Med; 1994 Jul; 118(7):712-4. PubMed ID: 8024406
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.